BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 20334478)

  • 21. Eradication of Helicobacter pylori in follicular and nonfollicular gastritis.
    Mehmet S; Ozdal E; Kamil O; Beşir K; Huseyin D; Nihat A; Cigdem EY; Nusret E
    Hepatogastroenterology; 2009; 56(91-92):930-4. PubMed ID: 19621732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pilot study: miscellaneous therapy is highly successful for Helicobacter pylori eradication.
    Sierra F; Forero JD; Rey M; Botero ML; Cárdenas A
    Aliment Pharmacol Ther; 2013 Jun; 37(12):1165-71. PubMed ID: 23656465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of three different proton pump inhibitors with amoxicillin and metronidazole in retreatment for Helicobacter pylori infection.
    Murakami K; Okimoto T; Kodama M; Sato R; Watanabe K; Fujioka T
    J Clin Gastroenterol; 2008 Feb; 42(2):139-42. PubMed ID: 18209581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of PPI, levofloxacin and amoxicillin in the eradication of Helicobacter pylori compared to conventional triple therapy at a Venezuelan hospital.
    Dib J; Alvarez B; Mendez L; Cruz ME
    Arab J Gastroenterol; 2013 Sep; 14(3):123-5. PubMed ID: 24206741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the effects of Helicobacter pylori eradication therapy on gastric antral epithelial hyperproliferation: a prospective six-month follow-up study.
    Demiray M; Gulten M; Manavoglu O; Evrensel T; Ulukaya E; Yerci O; Kanat O; Kurt E; Arslan M; Gonullu G; Demiray H; Gulten T; Memik F
    Hepatogastroenterology; 2004; 51(59):1531-5. PubMed ID: 15362794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of 1-week proton pump inhibitor triple therapy as first-line Helicobacter pylori eradication regime in Asian patients: is it still effective 10 years on?
    Qua CS; Manikam J; Goh KL
    J Dig Dis; 2010 Aug; 11(4):244-8. PubMed ID: 20649738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lansoprazole-based sequential and concomitant therapy for the first-line Helicobacter pylori eradication.
    Huang YK; Wu MC; Wang SS; Kuo CH; Lee YC; Chang LL; Wang TH; Chen YH; Wang WM; Wu DC; Kuo FC
    J Dig Dis; 2012 Apr; 13(4):232-8. PubMed ID: 22435509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequential therapy achieves a higher eradication rate than standard triple therapy in Taiwan.
    Tsay FW; Tseng HH; Hsu PI; Wang KM; Lee CC; Chang SN; Wang HM; Yu HC; Chen WC; Peng NJ; Lai KH; Wu DC
    J Gastroenterol Hepatol; 2012 Mar; 27(3):498-503. PubMed ID: 21871025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Helicobacter pylori eradication on the outcome of reflux esophagitis and chronic gastritis in the elderly. A randomized, multicenter, eight-month study.
    Pilotto A; Perri F; Leandro G; Franceschi M;
    Gerontology; 2006; 52(2):99-106. PubMed ID: 16508317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Healing of lymphocytic gastritis after Helicobacter pylori eradication therapy--a randomized, double-blind, placebo-controlled multicentre trial.
    Madisch A; Miehlke S; Neuber F; Morgner A; Kuhlisch E; Rappel S; Lehn N; Bayerdörffer E; Seitz G; Stolte M
    Aliment Pharmacol Ther; 2006 Feb; 23(4):473-9. PubMed ID: 16441467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
    Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.
    Stack WA; Knifton A; Thirlwell D; Cockayne A; Jenkins D; Hawkey CJ; Atherton JC
    Am J Gastroenterol; 1998 Oct; 93(10):1909-13. PubMed ID: 9772054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gatifloxacin-based triple therapy as a third-line regimen for Helicobacter pylori eradication.
    Nishizawa T; Suzuki H; Nakagawa I; Iwasaki E; Masaoka T; Hibi T
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S167-70. PubMed ID: 19120892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triple-drug combination therapy versus six-month proton pump inhibitor monotherapy in non-Helicobacter pylori Helicobacter eradication, and hyperacid environment preference of Helicobacter suis: a clinical study.
    Tsukadaira T; Hayashi S; Ota H; Kobayashi N; Agawa H; Kodaira H; Sekiguchi Y; Matsumoto T; Horiuchi K; Negishi T; Tada T
    BMC Gastroenterol; 2024 May; 24(1):157. PubMed ID: 38720287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen.
    Rokkas T; Sechopoulos P; Robotis I; Margantinis G; Pistiolas D
    Am J Gastroenterol; 2009 Jan; 104(1):21-5. PubMed ID: 19098844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ten-day sequential therapy as first-line treatment for Helicobacter pylori infection in Korea: a retrospective study.
    Kwon JH; Lee DH; Song BJ; Lee JW; Kim JJ; Park YS; Kim N; Jeong SH; Kim JW; Lee SH; Hwang JH; Jung HC; Song IS
    Helicobacter; 2010 Apr; 15(2):148-53. PubMed ID: 20402817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study.
    Assem M; El Azab G; Rasheed MA; Abdelfatah M; Shastery M
    Eur J Intern Med; 2010 Aug; 21(4):310-4. PubMed ID: 20603042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of CYP2C19 and MDR1 genotype on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxycillin and clarithromycin.
    Oh JH; Dong MS; Choi MG; Yoo HW; Lee SB; Park YI; Chung IS
    J Gastroenterol Hepatol; 2009 Feb; 24(2):294-8. PubMed ID: 18823430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resolution of gastritis induced by Helicobacter pylori 4-5 weeks after successful eradication of infection using a triple therapy regimen of pantoprazole, amoxycillin and clarithromycin for one week.
    Abdul Aal GM; Dajani AI; Nounou M; Awad S; Abdul Rasheed Z; Gautam S; Ukabam S; Nayal S
    Digestion; 1999; 60(3):286-97. PubMed ID: 10343145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized trial of standard-dose versus half-dose rabeprazole, clarithromycin, and amoxicillin in the treatment of Helicobacter pylori infection.
    Mansour NM; Hashash JG; El-Halabi M; Ghaith O; Maasri K; Sukkarieh I; Malli A; Sharara AI
    Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):865-70. PubMed ID: 21811161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.